首页 > 最新文献

BMC Cancer最新文献

英文 中文
Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer). 将Ki67和泛免疫炎症值(PIV)整合成三阴性乳腺癌病理完全缓解的预测nomogram: (Ki67和三阴性乳腺癌的炎症)。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-11 DOI: 10.1186/s12885-026-15842-5
Taliha Guclu, Ozgur Tanriverdi, Ismail Bayrakci, Bilgin Demir, Gokhan Colak, Sait Kitaplı, Ali Alkan, Gamze Gokoz-Doğu, Sernaz Topaloglu, Sabri Barutca
{"title":"Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer).","authors":"Taliha Guclu, Ozgur Tanriverdi, Ismail Bayrakci, Bilgin Demir, Gokhan Colak, Sait Kitaplı, Ali Alkan, Gamze Gokoz-Doğu, Sernaz Topaloglu, Sabri Barutca","doi":"10.1186/s12885-026-15842-5","DOIUrl":"https://doi.org/10.1186/s12885-026-15842-5","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quadruplet daratumumab in combination with bortezomib, lenalidomide, and dexamethasone as front-line regimen improved clinical outcomes in high-risk myeloma patients in China: a multi-centered prospective real-world study. daratumumab联合硼替佐米、来那度胺和地塞米松作为一线方案改善了中国高风险骨髓瘤患者的临床结果:一项多中心前瞻性现实世界研究。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15815-8
Lili Cheng, Dong Liang, Jing Jia, Runfeng Zhang, Yang Yang, Peng Liu, Hongli Sun, Xiaoqi Qin, Yanping Ma, Yin Wu, Hua Wang, Junling Zhuang
{"title":"Quadruplet daratumumab in combination with bortezomib, lenalidomide, and dexamethasone as front-line regimen improved clinical outcomes in high-risk myeloma patients in China: a multi-centered prospective real-world study.","authors":"Lili Cheng, Dong Liang, Jing Jia, Runfeng Zhang, Yang Yang, Peng Liu, Hongli Sun, Xiaoqi Qin, Yanping Ma, Yin Wu, Hua Wang, Junling Zhuang","doi":"10.1186/s12885-026-15815-8","DOIUrl":"https://doi.org/10.1186/s12885-026-15815-8","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic evidence for potential molecular mediators underlying the causal relationship between obesity and breast cancer: a two-step, two-sample Mendelian randomization study. 肥胖和乳腺癌之间因果关系的潜在分子介质的遗传证据:两步,两样本孟德尔随机化研究。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15744-6
Yu Hao, Xia Jiang, Jinyu Xiao, Mengyu Fan, Xueyao Wu, Jiaqiang Liao, Xunying Zhao, Wanting Feng, Hongbo Qi, Jiayuan Li

Background: Relationships between BMI and breast cancer risk have been widely reported in previous Mendelian randomization (MR) studies, but the underlying molecular mechanisms remain unclear. We conducted this comprehensive two-sample MR to investigate the mediating role of 8 circulating biomarkers linking genetically predicted BMI to breast cancer risk both individually and simultaneously.

Methods: A total of 281 BMI-associated single-nucleotide polymorphisms (SNPs) were used to estimate the associations of BMI with biomarker levels and breast cancer susceptibility. Instruments involving 8 ~ 364 SNPs were used to proxy 8 circulating biomarkers related to adipocytokine imbalance, chronic low-grade inflammation and insulin/insulin-like growth factor (IGF) axis dysregulation. Two-step MR mediation analyses were conducted to evaluate the indirect effects of a single biomarker in the relationship between genetically predicted BMI and breast cancer risk, and stepwise MR mediation analyses were employed to identify potential pathways involving multiple mediators.

Results: Genetically predicted BMI was positively correlated with genetically predicted circulating leptin (LEP), insulin (INS), and C-reactive protein (CRP) levels, with β values ranging from 0.166 to 0.453, and negatively correlated with IGF-1 levels (β=-0.118), whereas no statistically significant associations were found for adiponectin, resistin, soluble leptin receptor or insulin-like growth factor binding protein-3 levels. Two-step MR mediation analyses showed that in the association between genetically predicted BMI and breast cancer susceptibility (OR: 0.894; 95%CI: 0.832, 0.960; P = 2.06 × 10- 3), the indirect effect mediated by CRP was statistically significant (OR: 1.046; 95%CI: 1.014, 1.079; P = 4.83 × 10- 3), while no statistically significant indirect effects were detected for LEP, INS or IGF-1. Furthermore, stepwise MR mediation analyses with multiple mediators revealed that both the indirect effect mediated by CRP alone (OR: 1.040; 95%CI: 1.012, 1.070; P = 5.73 × 10- 3) and by the sequential combination of IGF-1 and CRP (OR: 1.003; 95%CI: 1.000, 1.005; P = 2.38 × 10- 2) were statistically significant.

Conclusions: Chronic low-grade inflammation is a vital pathway linking genetically predicted BMI to breast cancer risk. Genetically predicted BMI is associated with higher genetically predicted CRP levels, potentially through a pathway involving reduced IGF-1 levels, which may attenuate the inverse association between genetically predicted BMI and breast cancer risk.

背景:在之前的孟德尔随机化(MR)研究中,BMI与乳腺癌风险之间的关系已被广泛报道,但其潜在的分子机制尚不清楚。我们进行了这项全面的双样本MR研究,以单独和同时研究8种循环生物标志物与遗传预测BMI与乳腺癌风险之间的中介作用。方法:共使用281个BMI相关单核苷酸多态性(snp)来估计BMI与生物标志物水平和乳腺癌易感性的关系。使用涉及8 ~ 364个snp的仪器来代表与脂肪细胞因子失衡、慢性低度炎症和胰岛素/胰岛素样生长因子(IGF)轴失调相关的8种循环生物标志物。两步MR中介分析用于评估单个生物标志物在遗传预测BMI与乳腺癌风险之间的间接影响,并采用逐步MR中介分析来确定涉及多个介质的潜在途径。结果:遗传预测BMI与遗传预测循环瘦素(LEP)、胰岛素(INS)和c反应蛋白(CRP)水平呈正相关,β值范围为0.166 ~ 0.453,与IGF-1水平负相关(β=-0.118),而脂联素、抵抗素、可溶性瘦素受体或胰岛素样生长因子结合蛋白-3水平无统计学意义。两步MR中介分析显示,在遗传预测BMI与乳腺癌易感性的相关性(OR: 0.894; 95%CI: 0.832, 0.960; P = 2.06 × 10- 3)中,CRP介导的间接作用有统计学意义(OR: 1.046; 95%CI: 1.014, 1.079; P = 4.83 × 10- 3),而LEP、INS、IGF-1的间接作用无统计学意义。此外,多介质的逐步MR中介分析显示,CRP单独介导的间接效应(OR: 1.040; 95%CI: 1.012, 1.070; P = 5.73 × 10- 3)和IGF-1与CRP顺序联合介导的间接效应(OR: 1.003; 95%CI: 1.000, 1.005; P = 2.38 × 10- 2)均具有统计学意义。结论:慢性低度炎症是将基因预测的BMI与乳腺癌风险联系起来的重要途径。基因预测的BMI与较高的基因预测的CRP水平相关,可能通过降低IGF-1水平的途径,这可能减弱基因预测的BMI与乳腺癌风险之间的负相关。
{"title":"Genetic evidence for potential molecular mediators underlying the causal relationship between obesity and breast cancer: a two-step, two-sample Mendelian randomization study.","authors":"Yu Hao, Xia Jiang, Jinyu Xiao, Mengyu Fan, Xueyao Wu, Jiaqiang Liao, Xunying Zhao, Wanting Feng, Hongbo Qi, Jiayuan Li","doi":"10.1186/s12885-026-15744-6","DOIUrl":"https://doi.org/10.1186/s12885-026-15744-6","url":null,"abstract":"<p><strong>Background: </strong>Relationships between BMI and breast cancer risk have been widely reported in previous Mendelian randomization (MR) studies, but the underlying molecular mechanisms remain unclear. We conducted this comprehensive two-sample MR to investigate the mediating role of 8 circulating biomarkers linking genetically predicted BMI to breast cancer risk both individually and simultaneously.</p><p><strong>Methods: </strong>A total of 281 BMI-associated single-nucleotide polymorphisms (SNPs) were used to estimate the associations of BMI with biomarker levels and breast cancer susceptibility. Instruments involving 8 ~ 364 SNPs were used to proxy 8 circulating biomarkers related to adipocytokine imbalance, chronic low-grade inflammation and insulin/insulin-like growth factor (IGF) axis dysregulation. Two-step MR mediation analyses were conducted to evaluate the indirect effects of a single biomarker in the relationship between genetically predicted BMI and breast cancer risk, and stepwise MR mediation analyses were employed to identify potential pathways involving multiple mediators.</p><p><strong>Results: </strong>Genetically predicted BMI was positively correlated with genetically predicted circulating leptin (LEP), insulin (INS), and C-reactive protein (CRP) levels, with β values ranging from 0.166 to 0.453, and negatively correlated with IGF-1 levels (β=-0.118), whereas no statistically significant associations were found for adiponectin, resistin, soluble leptin receptor or insulin-like growth factor binding protein-3 levels. Two-step MR mediation analyses showed that in the association between genetically predicted BMI and breast cancer susceptibility (OR: 0.894; 95%CI: 0.832, 0.960; P = 2.06 × 10<sup>- 3</sup>), the indirect effect mediated by CRP was statistically significant (OR: 1.046; 95%CI: 1.014, 1.079; P = 4.83 × 10<sup>- 3</sup>), while no statistically significant indirect effects were detected for LEP, INS or IGF-1. Furthermore, stepwise MR mediation analyses with multiple mediators revealed that both the indirect effect mediated by CRP alone (OR: 1.040; 95%CI: 1.012, 1.070; P = 5.73 × 10<sup>- 3</sup>) and by the sequential combination of IGF-1 and CRP (OR: 1.003; 95%CI: 1.000, 1.005; P = 2.38 × 10<sup>- 2</sup>) were statistically significant.</p><p><strong>Conclusions: </strong>Chronic low-grade inflammation is a vital pathway linking genetically predicted BMI to breast cancer risk. Genetically predicted BMI is associated with higher genetically predicted CRP levels, potentially through a pathway involving reduced IGF-1 levels, which may attenuate the inverse association between genetically predicted BMI and breast cancer risk.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study. 突变检测残留核酸5基因表达谱诊断BRAF v600e阴性甲状腺乳头状癌的准确性:一项回顾性研究
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15818-5
Liang Wang, Wu Mao, Hua Deng, Wei-Ping Zhou, Liang Zhang, Jie Li
{"title":"Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study.","authors":"Liang Wang, Wu Mao, Hua Deng, Wei-Ping Zhou, Liang Zhang, Jie Li","doi":"10.1186/s12885-026-15818-5","DOIUrl":"https://doi.org/10.1186/s12885-026-15818-5","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy. 早期宫颈癌腹腔镜根治性子宫切除术与开放式根治性子宫切除术的预后分析。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15756-2
Yu-Meng Cui, Yu-Mei Shan, Yun-Yun Xiao, Yue Gao, Xiao-Chuan Yu, Meng Jiang, Hua-Li Wang
{"title":"Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.","authors":"Yu-Meng Cui, Yu-Mei Shan, Yun-Yun Xiao, Yue Gao, Xiao-Chuan Yu, Meng Jiang, Hua-Li Wang","doi":"10.1186/s12885-026-15756-2","DOIUrl":"https://doi.org/10.1186/s12885-026-15756-2","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of swallowing and communication after nasopharyngeal cancer in Malaysian men: a qualitative study. 马来西亚男性鼻咽癌后吞咽及沟通的经验:一项质性研究。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15606-1
Giuditta Smith, Ting Ying Boey, Shin Ying Chu, Caryn Mei Hsien Chan, Siti Fathiah Masre, Fuad Ismail, Maria Garraffa, Deborah Hersh
{"title":"Experiences of swallowing and communication after nasopharyngeal cancer in Malaysian men: a qualitative study.","authors":"Giuditta Smith, Ting Ying Boey, Shin Ying Chu, Caryn Mei Hsien Chan, Siti Fathiah Masre, Fuad Ismail, Maria Garraffa, Deborah Hersh","doi":"10.1186/s12885-026-15606-1","DOIUrl":"https://doi.org/10.1186/s12885-026-15606-1","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a SHAP-explainable preoperative predictive model for microvascular invasion in hepatocellular carcinoma. 肝细胞癌微血管侵袭的shap可解释术前预测模型的建立和验证。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15839-0
Jianxi Guo, Honggui Tang, Tao Xu, Yucong Zhang, Jian Kong, Sina Zhang
{"title":"Development and validation of a SHAP-explainable preoperative predictive model for microvascular invasion in hepatocellular carcinoma.","authors":"Jianxi Guo, Honggui Tang, Tao Xu, Yucong Zhang, Jian Kong, Sina Zhang","doi":"10.1186/s12885-026-15839-0","DOIUrl":"https://doi.org/10.1186/s12885-026-15839-0","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic landscape of Chinese colorectal cancer: insights into germline and somatic mutations. 中国结直肠癌的遗传景观:对种系和体细胞突变的见解。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-10 DOI: 10.1186/s12885-026-15626-x
Fazhi Zhao, Hexin Lin, Rui Han, Meng Wang, Lin Yang, Dianfeng Tian, Liangqi Zhong, Pengxin Zhang, Queling Liu
{"title":"Genetic landscape of Chinese colorectal cancer: insights into germline and somatic mutations.","authors":"Fazhi Zhao, Hexin Lin, Rui Han, Meng Wang, Lin Yang, Dianfeng Tian, Liangqi Zhong, Pengxin Zhang, Queling Liu","doi":"10.1186/s12885-026-15626-x","DOIUrl":"https://doi.org/10.1186/s12885-026-15626-x","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of treatment outcome in nasopharyngeal carcinoma patients. 鼻咽癌患者治疗结果的预测。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-09 DOI: 10.1186/s12885-026-15570-w
Guanzhi Zhou, Nanna M Sijtsema, Yan Li, Tiantian Zhai, Lihong Xi, Jun Li, Arjen van der Schaaf, Lisanne V van Dijk, Yingrui Shi, Pei Yang, Johannes A Langendijk
{"title":"Prediction of treatment outcome in nasopharyngeal carcinoma patients.","authors":"Guanzhi Zhou, Nanna M Sijtsema, Yan Li, Tiantian Zhai, Lihong Xi, Jun Li, Arjen van der Schaaf, Lisanne V van Dijk, Yingrui Shi, Pei Yang, Johannes A Langendijk","doi":"10.1186/s12885-026-15570-w","DOIUrl":"https://doi.org/10.1186/s12885-026-15570-w","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten-year pathology-based cancer registry at a tertiary referral hospital in Kenya (2015-2024): distribution of cancers and completeness of pathology reporting. 肯尼亚一家三级转诊医院十年病理癌症登记(2015-2024):癌症分布和病理报告的完整性
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-03-09 DOI: 10.1186/s12885-026-15813-w
Brian O Ayara, Samuel G Mukono, Rodney D Adam, Shahin Sayed
{"title":"Ten-year pathology-based cancer registry at a tertiary referral hospital in Kenya (2015-2024): distribution of cancers and completeness of pathology reporting.","authors":"Brian O Ayara, Samuel G Mukono, Rodney D Adam, Shahin Sayed","doi":"10.1186/s12885-026-15813-w","DOIUrl":"https://doi.org/10.1186/s12885-026-15813-w","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147376252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1